Rizatriptan Shortage Update: What Patients Need to Know in 2026

Is Rizatriptan in Shortage in 2026?

No. As of 2026, rizatriptan is not listed on the FDA's Drug Shortage Database, and the American Society of Health-System Pharmacists (ASHP) does not list it as an active shortage. Generic rizatriptan tablets are manufactured by multiple companies and the supply chain is stable.

However — and this is important — no national shortage does not mean every patient has easy access. A meaningful number of patients continue to report difficulty filling rizatriptan at their local pharmacy. Understanding why helps you find the right solution.

Rizatriptan Availability History

Rizatriptan (Maxalt) was first approved by the FDA in 1998. The original Merck patent expired, and generic versions became widely available in the mid-2010s. The introduction of multiple generic manufacturers dramatically increased supply and drove prices down. Unlike controlled substances such as Adderall or stimulant medications, rizatriptan has no DEA production quota, which means manufacturers can produce as much as market demand requires.

There has been no documented nationwide rizatriptan shortage in recent years. The drug has had a stable supply chain, and there are no known manufacturing site issues that would create a sustained shortage.

Why Some Patients Still Struggle to Get Rizatriptan

If the supply is fine, why are patients struggling? The reasons are almost always access-related, not supply-related:

Pharmacy doesn't stock it. Many chain pharmacies use demand-based inventory algorithms. If your local CVS or Walgreens doesn't fill many rizatriptan prescriptions, it may not keep stock on hand — especially for the ODT formulation. This creates a frustrating "not in stock" experience that mimics a shortage but is really just a restocking delay.

Insurance quantity limits. Most insurance plans restrict triptans to 9 tablets per 30-day period. Medicare Part D typically places rizatriptan on Tier 2, with quantity limits. Patients who have already hit their monthly limit may feel like the drug is "unavailable" when the issue is actually an insurance restriction.

Step therapy requirements. Some insurance plans require patients to first try and fail on a cheaper triptan (usually sumatriptan) before they'll approve rizatriptan. This can delay access for weeks during the prior authorization process.

ODT form harder to find than tablets. The orally disintegrating tablet formulation has fewer generic manufacturers than the standard tablet. Pharmacies may stock the tablet but not the ODT, and patients who need the ODT specifically may need to shop around.

What to Do If Your Pharmacy Says Rizatriptan Is Unavailable

First, ask your pharmacist to clarify: is this a physical stock issue, or an insurance rejection? The answer changes your next step significantly.

If it's a stock issue:

Ask your pharmacist to order it — most can receive it from their wholesaler within 1-2 business days.

Try an independent pharmacy — they often have more flexibility than chains.

Use medfinder — medfinder calls pharmacies near you to find out which ones currently have rizatriptan in stock, saving you hours of phone calls.

If it's an insurance issue:

Contact your doctor to request a prior authorization or step therapy override.

Ask your doctor if you can use a discount coupon (GoodRx, SingleCare) to pay cash — generic rizatriptan can cost as little as $7-$13 for 9 tablets with coupons.

If your plan requires step therapy, ask your doctor to document any prior triptan trials in your medical record to support the PA request.

When Should Patients Consider an Alternative?

If you've had consistent difficulty filling rizatriptan for more than one or two cycles, it's worth talking to your doctor about whether another triptan or a newer migraine medication might work as well and be easier to access. See Alternatives to Rizatriptan If You Can't Fill Your Prescription for a full comparison.

Bottom Line for Patients in 2026

Rizatriptan is not in shortage. The drug is widely manufactured and distributed. If you're having trouble filling it, the problem is almost certainly a local pharmacy stocking decision, an insurance barrier, or a formulation availability issue — all of which have practical solutions. Don't wait until a migraine starts to figure this out. Set up a plan with your doctor now so you always have a reliable supply.